England's pharmacies take on more minor illnesses to ease NHS strain

Community pharmacies in England are taking on a bigger role in treating minor illnesses. The move aims to ease pressure on GP surgeries and emergency departments. A major expansion of the Pharmacy First scheme was announced as part of a £340 million investment package. The Pharmacy First programme launched in early 2024. It allows pharmacists to diagnose and prescribe medicines for seven common conditions without needing GP approval. Between March 2025 and February 2026, over 3.3 million consultations took place under the scheme.

Pharmacies now offer support for issues affecting the eyes, ears, mouth, and digestive system. They also provide blood pressure checks and contraception services. From autumn 2026, the programme will extend to cover five more conditions. By 2026, all newly trained pharmacists must qualify as independent prescribers. Despite the expansion, pharmacy leaders have raised concerns about ongoing financial pressures in the sector.

The scheme’s growth reflects a shift towards pharmacies handling more minor health concerns. With millions already benefiting, the changes are set to further reduce strain on GPs and hospitals. The £340 million funding will support wider access to pharmacy-led care across England.